Dechra Pharmaceuticals PLC
DPHAY · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,500 | $22,600 | $17,500 | $40,700 |
| Dep. & Amort. | $41,100 | $8,600 | $36,300 | $7,400 |
| Deferred Tax | $46,400 | $7,000 | $56,900 | -$17,500 |
| Stock-Based Comp. | -$2,600 | $1,800 | $2,000 | $1,300 |
| Change in WC | -$43,800 | -$8,800 | -$58,900 | $16,200 |
| Other Non-Cash | $21,500 | $20,300 | -$19,000 | $22,500 |
| Operating Cash Flow | $12,100 | $51,500 | $34,800 | $88,100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12,300 | -$10,500 | -$9,100 | -$11,200 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,700 | -$397,700 | -$19,400 | -$38,600 |
| Investing Cash Flow | -$18,000 | -$408,200 | -$28,500 | -$49,800 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$14,300 | -$37,400 | -$13,000 | -$31,800 |
| Other Fin. Act. | $9,400 | $358,800 | -$1,100 | -$200 |
| Financing Cash Flow | -$4,900 | $321,400 | -$14,100 | -$32,000 |
| Forex Effect | -$2,700 | $2,300 | $5,000 | -$1,000 |
| Net Chg. in Cash | -$6,750 | -$16,500 | -$1,400 | $2,650 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $121,050 |
| End Cash | -$6,750 | -$16,500 | -$1,400 | $123,700 |
| Free Cash Flow | -$200 | $41,000 | $25,700 | $76,900 |